In Thursday’s Analysts’ Actions, Wall Street firms are giving Merck & Co. (MRK), Cisco Systems (CSCO), and Alibaba (BABA) some attention. Merck was upgraded by analysts at BMO Capital Markets to OUTPERFORM from MARKET PERFORM. The firm has a positive outlook on the pharmaceutical giant’s pipeline, and analysts pointed out that drugs like Januvia and Keytruda are impressive. Looking ahead, the company looks like it will finish strong in the second half of 2015, analysts added. The firm also lifted its price target to $70 from $65. Wall Street analysts are also bullish on Cisco Systems. Cantor Fitzgerald raised its price target to $38 from $36 and reiterated its BUY rating on the stock. The IT leader distinguishes itself from other vendors, analysts stated. On Wednesday, the company posted strong fourth quarter 2015 results that beat analysts’ estimates on both the top and bottom line. The firm noted that the company’s public and commercial markets are performing well, which makes the stock attractive. Cantor Fitzgerald however lowered its price target on Alibaba’s stock to $95 from $110. This action comes as the e-commerce on Wednesday reported mixed earnings results. Revenue came in below consensus estimates while earnings came in ahead. Its latest quarter was hurt by the suspension of Alibaba’s lottery business along with slow user growth, the firm noted. But, the firm’s long-term outlook is positive as Alibaba continues to dominate the fast-growing Chinese e-commerce market. Cantor Fitzgerald reiterated its BUY rating on the stock. TheStreet’s U-Jin Lee reports.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
